Entities, activists and carriers of HIV and AIDS launched the campaign #ANTIRETROVIRALESYA to denounce the shortage of antiretroviral drugs in Venezuela, which is now on 100%. The campaign aims to raise awareness institutions, civil society organizations and the entire international community to the drama experienced by people living with HIV and AIDS in the country. From January 3, 2018 to this date, there have been registered 3120 deaths due to HIV and AIDS.

A new research published in The Lancet HIV journal conducted by the social scientist Martin Holt of the University of New South Wales interviewed nearly 17,000 men who have sex with men (MSM) in the cities of Sydney and Melbourne between 2013 and 2017. According  the publication “Science”, during this time, the number of HIV-negative participants who was in PrEP treatment jumped of 2% for 24%.

On the eve of the 2018 International AIDS Conference that takes place in Amsterdam (Netherlands) in July, the Global Public Health Journal, one of the main academic publications on global health, released its latest volume “Special Symposium: Critical Perspectives on the ‘End of AIDS”, an issue that reunites a collection of articles on the too optimistic belief that the AIDS epidemic is set on a horizon that will, by 2030 or very soon, come to an end.

Anvisa, the National Health Surveillance Agency in Brazil, has registered a generic version of the medicine sofosbuvir on May 21, which is used for the treatment of hepatitis C and also for patients co-infected with HIV/AIDS.